May 8 |
Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
|
May 7 |
Protagonist GAAP EPS of $3.26, revenue of $254.95M
|
May 7 |
Protagonist Therapeutics to Participate in the Citizens JMP Life Sciences Conference and the Capital One 1st Annual Biotech/Biopharma Disruptors Event
|
May 7 |
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
Apr 29 |
We Might See A Profit From Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Soon
|
Apr 16 |
Turnstone Biologics Appoints William Waddill to its Board of Directors
|
Apr 5 |
All You Need to Know About Protagonist Therapeutics (PTGX) Rating Upgrade to Buy
|
Apr 3 |
Protagonist Therapeutics Inc CEO Sells 25,000 Shares
|
Apr 1 |
Shareholders have faith in loss-making Protagonist Therapeutics (NASDAQ:PTGX) as stock climbs 3.7% in past week, taking five-year gain to 135%
|
Mar 26 |
Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data
|